Andrea Corcoran
Chief Financial Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Atea Pharmaceuticals, Inc. (AVIR) | Chief Financial Officer, Executive Vice President, Legal | $549,530 | $1,690,428 |
| 2024 | Atea Pharmaceuticals, Inc. (AVIR) | Chief Financial Officer, Executive Vice President, Legal | $533,524 | $1,931,832 |
| 2023 | Atea Pharmaceuticals, Inc. (AVIR) | Chief Financial Officer, Executive Vice President, Legal | $517,984 | $1,961,524 |
| 2022 | Atea Pharmaceuticals, Inc. (AVIR) | Chief Financial Officer, Executive Vice President, Legal | $493,319 | $1,959,897 |
| 2021 | Atea Pharmaceuticals, Inc. (AVIR) | Chief Financial Officer, Executive Vice President, Legal | $478,950 | $8,357,169 |
| 2020 | Atea Pharmaceuticals, Inc. (AVIR) | Chief Financial Officer, Executive Vice President, Legal | $465,000 | $1,488,000 |
| 2019 | Atea Pharmaceuticals, Inc. (AVIR) | Chief Financial Officer, Executive Vice President, Legal | $290,000 | $440,324 |
Earnings-call appearances
-
Atea Pharmaceuticals, Inc. Q1 FY2026 Earnings Call2026-05-12
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q4 FY2025 Earnings Call2026-03-05
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-11-12
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-08-07
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-01-14
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-11-07
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-08-07
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-05-14
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-02-28
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-11-08
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q2 FY2023 Earnings Call2023-08-08
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-05-08
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q4 FY2022 Earnings Call2023-02-28
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-11-07
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q2 FY2022 Earnings Call2022-08-08
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-05-10
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q4 FY2021 Earnings Call2022-02-28
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-11-12
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-08-12
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q1 FY2021 Earnings Call2021-05-13
Atea Pharmaceuticals, Inc. (AVIR)